spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  opioid 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 15 Apr 2026
Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes
Diagnostics Product Launch FDA
 HSMN NewsFeed - 14 Apr 2026
Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion
Devices Mergers & Acquisitions
 HSMN NewsFeed - 23 Jul 2025
Neuros Medical Announces First Commercial Implant of the Altius(R) Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
Devices Neurology FDA
 HSMN NewsFeed - 9 Jul 2025
Neuros Medical Secures $56M Series D to Commercialize the Altius(R) System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Devices Venture Capital
 HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 4 Mar 2025
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
Devices Neurology Venture Capital
 HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Oct 2024
Protega Pharmaceuticals Receives FDA Approval for ROXYBOND(TM) (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Aug 2024
Neuros Medical Receives FDA Approval for the Altius(R) Direct Electrical Nerve Stimulation System
Devices FDA
 HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 7 Aug 2023
NRx Pharmaceuticals Announces the Licensure of a US Patent to Support Use of NRX-101(TM) for Chronic Pain
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Jun 2023
Genesys Spine Launches SIros O(TM) Transfixing SI Joint Fusion System
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA
 HSMN NewsFeed - 26 Dec 2022
Harm Reduction Therapeutics' New Drug Application for RiVive(TM) Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Oct 2022
DePuy Synthes Receives FDA Clearance for TELIGEN(TM) System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 26 Sep 2022
Innocoll and DURECT Announce U.S. launch of POSIMIR(R)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 2 May 2022
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Mar 2022
Spine BioPharma Completes Series B Financing
Biopharmaceuticals Orthopaedic Venture Capital
 HSMN NewsFeed - 17 Mar 2022
Heron Therapeutics Announces Approval of ZYNRELEF(R) by Health Canada for the Management of Postoperative Pain
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 8 Mar 2022
Electromedical Announces Addition of David Orn as Director of Business and Sales Development
Devices Personnel
 HSMN NewsFeed - 11 Feb 2022
Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine
Devices Neurosurgery
 HSMN NewsFeed - 30 Sep 2021
Electromedical Technologies Receives Key Medical Device Certification
Devices Regulatory
 HSMN NewsFeed - 5 Aug 2021
Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led By Sorrento Therapeutics And Including Existing Investors And The Foundation For Prader-Willi Research
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jul 2021
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 25 Jun 2021
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 May 2021
Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2021
Nevro Appoints Jon R. Shear as Vice President, Corporate Development
Devices Personnel
 HSMN NewsFeed - 12 Apr 2021
Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2021
BrainCool AB (publ) Receives FDA "Breakthrough Device" Designation for Cooral(R) System for Prevention of Oral Mucositis
Devices FDA
 HSMN NewsFeed - 2 Feb 2021
DURECT Corporation Announces U.S. FDA Approval of POSIMIR(R) For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Dec 2020
Moebius Medical Announces FDA Clearance of IND Application for Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain
Biopharmaceuticals Orthopaedic FDA
 HSMN NewsFeed - 15 Dec 2020
Medtronic's OsteoCool(TM) Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients
Devices Interventional Oncology
 HSMN NewsFeed - 8 Dec 2020
Vertos Medical Announces ASC Reimbursement Increase for the mild(R) Procedure
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2020
Titan Pharmaceuticals Provides a Strategic & Corporate Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2020
REYVOW(R) (lasmiditan) C-V Demonstrated Superior Pain Freedom At 2 Hours in At Least 2 of 3 Migraine Attacks in New Phase 3 Consistency of Effect Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Sep 2020
Israeli Pain Monitoring Startup Medasense Raises $18M in Series C Round
Devices Monitoring Venture Capital
 HSMN NewsFeed - 18 Sep 2020
BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020
Devices Oncology
 HSMN NewsFeed - 11 Sep 2020
REYVOW(TM) (lasmiditan) C-V Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase 3 Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Devices Monitoring
 HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Jul 2020
FDA Clears Abivertinib for Phase 2 Safety and Efficacy Study in Hospitalized Patients with Moderate To Severe Covid-19
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jul 2020
NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield
Devices Distribution
 HSMN NewsFeed - 2 Jul 2020
Orexo Launches Deprexis(R) and Vorvida(R) in the US and Provides Updated Financial Guidance
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 8 Jun 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO(R) (Diazepam Nasal Spray)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 4 Jun 2020
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 29 May 2020
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 May 2020
Travecta Therapeutics Secures $15 Million in Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 11 May 2020
Orexo Acquires Exclusive US Rights to Commercialize deprexis(R), A World-leading Digital Therapy to Help Patients Manage the Symptoms of Depression
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Apr 2020
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 20 Apr 2020
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Mar 2020
Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Feb 2020
Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction
Devices Neurology Litigation
 HSMN NewsFeed - 28 Feb 2020
Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S.
Devices Neurology Litigation
 HSMN NewsFeed - 25 Feb 2020
Mallinckrodt Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities
Biopharmaceuticals Litigation
 HSMN NewsFeed - 22 Jan 2020
Soin Neuroscience Develops A New Spinal Cord Stimulator to Treat Chronic Pain
Devices Neurology
 HSMN NewsFeed - 20 Jan 2020
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
Devices Neurology Personnel
 HSMN NewsFeed - 17 Jan 2020
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR(R)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 30 Dec 2019
Avanos Medical Appoints Michael C. Greiner as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 18 Dec 2019
Nevro Appoints Karen N. Prange to the Company's Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 2 Dec 2019
Orexo Appoints Dennis Urbaniak as Executive Vice President Digital Health
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2019
CTT Pharma Strengthens Board and Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Nov 2019
Aruvant Appoints William Chou as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2019
NanoVibronix PainShield(R) Device Receives Unique Reimbursement Code from Centers for Medicare and Medicaid (CMS)
Devices Reimbursement
 HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Nov 2019
Nevro Announces U.S. Launch of Senza(R) Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
Devices Neurology FDA Product Launch
 HSMN NewsFeed - 23 Oct 2019
Zyla Life Sciences Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2019
AmacaThera Closes Seed Financing Round
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 2 Oct 2019
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR(R) for the Treatment of Post-Surgical Pain
Biopharmaceuticals Drug Delivery Surgery FDA
 HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2019
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 17 Sep 2019
BioQ Pharma Announces Partnership with Avanos Medical
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 17 Jul 2019
FDA Clears Erchonia's FX 635 for Relief of Chronic Musculoskeletal Pain
Devices FDA
 HSMN NewsFeed - 28 Jun 2019
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
Biopharmaceuticals Generics Distribution Product Launch
 HSMN NewsFeed - 27 Jun 2019
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Jun 2019
DURECT Announces $15 Million Registered Direct Offering
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 4 Jun 2019
Braeburn Announces Publication of Phase 3 Study Results Showing Long-term Safety and Effectiveness of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2019
Saluda Medical Announces Clinical Study Results for Evoke(R) ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain
Devices Neurosurgery
 HSMN NewsFeed - 28 May 2019
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 May 2019
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 May 2019
Nektar Announces the Launch of Inheris Biopharma, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 May 2019
Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 25 Apr 2019
DURECT Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 11 Mar 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2019
Lannett Enters Into Distribution Agreement For Generic Adderall(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 4 Mar 2019
COOLIEF* Cooled Radiofrequency Achieves Statistically Significant Reductions in Pain and Improved Function Compared to Hyaluronic Acid Injection
Devices Orthopaedic
 HSMN NewsFeed - 22 Feb 2019
Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence
Biopharmaceuticals Drug Delivery Generics Product Launch
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2019
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Dec 2018
FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 19 Dec 2018
Commercial Launch Plans Announced for PERSERIS(TM) (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 Nov 2018
BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversion
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 28 Nov 2018
Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron(TM) from GE Healthcare
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 23 Nov 2018
Indivior Announces Health Canada Approval of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Nov 2018
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Devices Neurology FDA Regulatory Product Launch
 HSMN NewsFeed - 14 Nov 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Narcan(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Oct 2018
FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
Devices Drug Delivery Neurology FDA
 HSMN NewsFeed - 12 Oct 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Oct 2018
U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone(R) (Oxycodone Hydrochloride)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Oct 2018
First Patient Enrolled in Vertos Medical's New MOTION Study of MILD(R) Procedure, a Minimally Invasive Treatment for Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 1 Oct 2018
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 28 Sep 2018
EO2 Announces Positive Results from Two Recent Studies: Double-Blind Randomized Study Evaluates Continuous Diffusion of Oxygen in Patients with Chronic Wounds & Second Pilot Study Builds on Growing Body of Clinical Evidence for the EO2 O2 Delivery System
Devices Wound Care
 HSMN NewsFeed - 21 Sep 2018
CHMP Recommends Approval of Buvidal(R) (CAM2038) for the Treatment of Opioid Dependence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Sep 2018
SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Aug 2018
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Aug 2018
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 13 Jul 2018
Modus Therapeutics Completes a SEK 140 Million Financing led by HealthCap
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jul 2018
Sorrento Acquires the Sofusa(TM) Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
Biopharmaceuticals Oncology Drug Delivery Acquisitions
 HSMN NewsFeed - 27 Jun 2018
AcelRx receives European Commission approval for DZUVEO(TM)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 26 Jun 2018
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 26 Jun 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2018
Halyard Health Announces Agreement to Acquire CoolSystems, Inc., Marketed as Game Ready(R)
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 1 Jun 2018
Halyard Health Announces Corporate Rebranding, Changes Name to Avanos Medical, Inc.
Devices
 HSMN NewsFeed - 31 May 2018
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
Devices Drug Delivery Licensing
 HSMN NewsFeed - 29 May 2018
ADAPT Pharma(R) Launches NARCANDirect.com
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 25 May 2018
Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 15 May 2018
Lilly's Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 May 2018
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 May 2018
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery Surgery Licensing
 HSMN NewsFeed - 3 May 2018
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 27 Apr 2018
AcelRx receives positive CHMP opinion for DZUVEO(TM) for management of acute moderate to severe pain in medically monitored settings
Biopharmaceutical Drug Delivery Regulatory
 HSMN NewsFeed - 25 Apr 2018
FDA Grants Fast Track Designation for OrphoMed's ORP-101 for Treatment of IBS-D
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 24 Apr 2018
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Apr 2018
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2018
Halyard Health, Inc. Appoints Sarker as Senior Vice President, International
Devices Personnel
 HSMN NewsFeed - 22 Mar 2018
Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron(TM) 1Xi Minute Ventilation Monitor in Pediatric Patients
Devices FDA
 HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2018
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Mar 2018
Pharmaceutical Startup, Bridge Therapeutics, Announces Tim Peara Will Be Joining the Company as the Director of Finance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Mar 2018
New Medical Policy Makes the Bioness StimRouter(R) Neuromodulation System a Covered Benefit for Highmark Blue Cross Blue Shield Policy Holders
Devices Neurology Reimbursement
 HSMN NewsFeed - 1 Mar 2018
SUBLOCADE(TM) (Buprenorphine Extended-Release) is Now Available as First and Only Monthly Injectable Buprenorphine in the U.S. to Treat Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 21 Feb 2018
Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2018
Bioness Receives Health Canada Approval for StimRouter Neuromodulation System
Devices Neurology Regulatory
 HSMN NewsFeed - 29 Jan 2018
Paradigm Spine Announces Landmark Publication Of coflex(R) Vs. Decompression Alone In The Journal Of Neurosurgery Spine
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 22 Jan 2018
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2018
USRM Reaches Key Sales Milestone of Proprietary Adipocell(TM) Product
Regenerative Medicine
 HSMN NewsFeed - 11 Jan 2018
Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter(TM) Spinal Cord Stimulator System
Devices Neurology FDA
 HSMN NewsFeed - 8 Jan 2018
Nevro Receives FDA Approval for Senza II(TM) Spinal Cord Stimulation System Delivering HF10(TM) Therapy
Devices FDA
 HSMN NewsFeed - 4 Jan 2018
Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS(R) for the Management of Post-operative Nausea & Vomiting
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2017
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA(R) (iobenguane I 131) in Pheochromocytoma and Paraganglioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Dec 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2017
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Devices Neurology Reimbursement
 HSMN NewsFeed - 27 Nov 2017
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 15 Nov 2017
Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 14 Nov 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA advisory about deadly risks associated with Kratom
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2017
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2017
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 3 Oct 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2017
Halyard Health Announces New Data Supporting COOLIEF* Cooled RF for the Treatment of Chronic Osteoarthritis Knee Pain
Devices Orthopaedic
 HSMN NewsFeed - 6 Sep 2017
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Sep 2017
ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 31 Aug 2017
Daiichi Sankyo Terminates Development and Commercialization Agreement with Charleston Laboratories Regarding Hydrocodone Products in the U.S., including CL-108
Biopharmaceuticals
 HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Aug 2017
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 Aug 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba(TM) in Germany, France and Austria
Biopharmaceuticals Distribution
 HSMN NewsFeed - 1 Aug 2017
AcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 31 Jul 2017
Immunalysis Receives FDA Clearance for SEFRIA(TM) Fentanyl Urine Drug Screening Test
Diagnostics FDA
 HSMN NewsFeed - 12 Jul 2017
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA(R) In Canada
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 23 Jun 2017
Halyard Health Announces CEO Transition
Devices Personnel
 HSMN NewsFeed - 22 Jun 2017
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR(R)
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jun 2017
Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2017
Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE(R) in Canada for Opioid Drug Dependence
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 May 2017
EarlySense Launches New Software Update, Further Extends Benefits of Continuous Patient Monitoring
Devices Monitoring Product Launch
 HSMN NewsFeed - 15 May 2017
Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 May 2017
Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 May 2017
Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Results from Long-term Phase 3 Safety Study of CAM2038
Biopharmaceuticals
 HSMN NewsFeed - 2 May 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba(R) (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Apr 2017
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond(TM) (oxycodone hydrochloride) tablets CII, the First and Only Immediate Release Opioid Analgesic with Abuse-Deterrent Label Claims
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
Devices Orthopaedic FDA
 HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2017
Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Mar 2017
Pain Therapeutics Announces Positive Regulatory Guidance for REMOXY(TM) ER
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Mar 2017
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed(R) Products
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 10 Mar 2017
Tris Pharma Appoints New Chief Commercial Officer for Brand Business
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 Mar 2017
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2017
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage(R) XR
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Feb 2017
Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista(TM) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2017
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
Devices Orthopaedic Distribution
 HSMN NewsFeed - 19 Jan 2017
Ethypharm Acquires Martindale Pharma in the UK
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 10 Jan 2017
Adynxx Announces Closing of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jan 2017
Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2017
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Dec 2016
Innocoll Receives Refusal to File Letter from U.S. FDA for XARACOLL(R) (bupivacaine HCl collagen-matrix implants) New Drug Application
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Dec 2016
Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2016
Orexo Appeals Zubsolv(R) US District Court Decision
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Nov 2016
Intellipharmaceutics Submits New Drug Application for Rexista(R) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2016
Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 13 Oct 2016
Chromocell and Astellas Announce FDA Fast Track Designation and First Subject Dosing with Lead Candidate CC8464/ASP1807 for the Management of Neuropathic Pain Associated with iSFN
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Oct 2016
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Sep 2016
Insys Therapeutics Announces CEO Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Sep 2016
Egalet Appoints Patrick Shea as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2016
BlueWind Medical Announces CE-Mark for the BlueWind VIVENDI(TM) Miniature Implanted Wireless Stimulator to Treat Peripheral Pain
Devices Neurology Regulatory
 HSMN NewsFeed - 6 Sep 2016
Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10(TM) Therapy over Traditional Spinal Cord Stimulation for Chronic Pain
Devices Neurology
 HSMN NewsFeed - 29 Aug 2016
Elite Announces Development and License Agreement with SunGen Pharma LLC
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 12 Aug 2016
Flamel Technologies Launches Akovaz(TM)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 1 Aug 2016
Orexigen Completes Acquisition of All U.S. Rights to Contrave(R) and Launches U.S. Sales Organization
Biopharmaceuticals Acquisitions Product Launch
 HSMN NewsFeed - 27 Jul 2016
Boston Scientific Announces Acquisition of Cosman Medical
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 5 Jul 2016
Recro Pharma Appoints Michael Celano as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 30 Jun 2016
Martindale Pharma(R) Announces Extension of Licensing Agreement With Unimedic AB to Include Emergency Care Product Portfolio
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Jun 2016
Collegium Announces Election of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Jun 2016
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Jun 2016
Bayer and Orion Expand Clinical Development Program for BAY-1841788 (ODM-201) in Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation
 HSMN NewsFeed - 19 May 2016
Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2016
Elite Pharmaceuticals to Present SequestOx(TM) Data at the American Pain Society 35th Annual Scientific Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 May 2016
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2016
Study Shows Minute Ventilation Preferred Over End-Tidal CO(2) In Monitoring For Life-Threatening Opioid Induced Respiratory Depression
Devices Monitoring
 HSMN NewsFeed - 12 Apr 2016
Elite Pharmaceuticals Announces Changes to their Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2016
Adapt Pharma Names Mike Kelly President of U.S. Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2016
Braeburn Pharmaceuticals and Camurus Announce Enrollment Goals Reached in Two Pivotal Phase 3 Trials of Cam2038 for Treatment of Opioid Dependence
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2016
Pain Therapeutics Resubmits REMOXY New Drug Application to the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Mar 2016
Elite Announces U.S. FDA Priority Review Designation for SequestOx(TM) NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Mar 2016
Immune Therapeutics, Inc., Appoints Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Feb 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Feb 2016
Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 16 Feb 2016
Nutra Pharma Announces Management Expansion and Business Updates
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2016
Recro Pharma Appoints Fred Graff as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Biopharmaceuticals Distribution Product Launch
 HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 Jan 2016
AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 19 Jan 2016
Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 13 Jan 2016
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2016
AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso(TM) in 1Q 2016
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Dec 2015
Braeburn Pharmaceuticals and Camurus Enroll First Patient in a Phase 3 Efficacy Trial of Long-acting Treatment for Opioid Dependence
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2015
Allergan Announces U.S. Availability of VIBERZI(TM) (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 9 Nov 2015
Collegium Announces FDA Tentative Approval for Xtampza(TM) ER, a Novel Abuse-Deterrent Analgesic for Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2015
Recro Pharma Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 14 Oct 2015
Impel NeuroPharma Closes First Tranche of Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 12 Oct 2015
Heron Therapeutics Appoints Neil J. Clendeninn, M.D., Ph.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2015
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2015
AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Aug 2015
Flowonix Medical, Inc. Announces First Use of Its Patient Therapy Controller (PTC(TM))
Devices Drug Delivery Product Launch
 HSMN NewsFeed - 17 Aug 2015
European Commission Grants Marketing Authorisation for Unituxin(TM) (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Jul 2015
AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 16 Jul 2015
Relmada Therapeutics Appoints Charles J. Casamento to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2015
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2015
Zalviso(TM) Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 21 May 2015
Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel(TM) XR
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 23 Apr 2015
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2015
Pain Therapeutics Resumes Responsibility for REMOXY
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Mar 2015
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2015
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Jan 2015
Mundipharma receives positive European Commission decision on Targin(R) (oxycodone/naloxone) for the treatment of Restless Legs Syndrome1
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Nov 2014
Titan Pharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2014
Elite Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2014
AcelRx Pharmaceuticals Provides Regulatory Update on Zalviso(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2014
Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2014
Yale-New Haven Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes
Devices Monitoring
 HSMN NewsFeed - 2 Jul 2014
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Jun 2014
Tris Pharma Expands R&D Team with addition of Chief Medical Officer and Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2014
Trevi Therapeutics Announces $25 Million Series B Financing Led by TPG Biotech for Development of Nalbuphine ER
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 May 2014
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2014
Charleston Laboratories, Inc., Bolsters Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2014
Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Apr 2014
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2014
Astellas Announces European Regulatory Submission For XTANDI(R) (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Mar 2014
Xenon and Genentech Establish New Pain Discovery Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Jan 2014
Theravance Appoints Frank Pasqualone Senior Vice President, Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
KemPharm Strengthens its Board of Directors as Company Prepares for Multiple Clinical and Business Milestones in 2014
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2013
AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO(TM)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 13 Dec 2013
QRxPharma Completes A$11.6 Million Capital Raising
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Dec 2013
Orexo Announces the Launch of Abstral(R) in Japan
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 11 Dec 2013
Relmada Therapeutics Inc. Appoints Douglas J. Beck As Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific Reports Favorable Results Assessing Real-World Experience with the Precision Spectra(TM) Spinal Cord Stimulator System
Devices Neurology
 HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Dec 2013
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Nov 2013
U.S. Food and Drug Administration (FDA) Extends Review of Mallinckrodt’s New Drug Application for XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII)
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Nov 2013
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 21 Oct 2013
Cubist Announces FDA Approval for Expanded Use of ENTEREG(R)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 11 Oct 2013
Covidien Launches New Capnography Monitoring Solution
Devices Monitoring Product Launch
 HSMN NewsFeed - 8 Oct 2013
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Sep 2013
Rochester General Health System Installs Masimo Patient SafetyNet(TM) for Advanced Care and Oversight of Patients
Devices Monitoring
 HSMN NewsFeed - 20 Aug 2013
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 20 Aug 2013
Enteris BioPharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand "Peptelligence(TM) Partnering" Program
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 12 Aug 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2013
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim asElite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2013
BioDelivery Sciences Announces Regulatory Approval of ONSOLIS in Taiwan
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Jul 2013
BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Jul 2013
Tris Pharma's Generic Pharmaceuticals Business Launches Dextroamphetamine Sulfate Oral Solution
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 5 Jul 2013
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Jun 2013
Tris Pharma Hires President for Generic Pharmaceuticals Business
Biopharmaceuticals Generics Drug Delivery Personnel
 HSMN NewsFeed - 20 Jun 2013
DURECT Announces FDA Acceptance of New Drug Application (NDA) Submission for POSIDUR(R) (SABER(R)-Bupivacaine)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Jun 2013
Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 29 May 2013
Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL in Femoral Nerve Block for Total Knee Arthroplasty
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2013
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 May 2013
New Clinical Study Finds Masimo rainbow(R) Acoustic Monitoring(TM) Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical Patients
Devices Monitoring
 HSMN NewsFeed - 6 May 2013
FDA Grants Premarket Approval (PMA) For The SEDASYS(R) System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures
Devices Drug Delivery Gastroenterology Oncology FDA
 HSMN NewsFeed - 29 Apr 2013
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Mar 2013
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Devices Orthopaedic
 HSMN NewsFeed - 25 Feb 2013
Actavis' Generic Suboxone(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Feb 2013
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection To Sandor Medicaids Pvt. Ltd. For Commercialization In India
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 20 Feb 2013
University of Virginia Medical Center Installs Masimo Noninvasive rainbow(R) Technologies to Improve Patient Assessments and Speed Clinical Decisions
Devices Monitoring
 HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Feb 2013
Orexo strengthens the commercial leadership structure and appoints Nikolaj Sørensen as new CEO and Martin Nicklasson as Executive Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 17 Jan 2013
Collegium Pharmaceutical Announces Relocation to Massachusetts
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Dec 2012
AcelRx to Present Top-Line Data from Phase 3 Study of Sufentanil NanoTab(R) PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company Agrees to Acquire Incline Therapeutics, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2012
Tris Pharma Appoints New Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 12 Nov 2012
Trinity Medical Center Adds Masimo Patient SafetyNet(TM) as a High Vigilance Safeguard for Post-Surgical Patients
Devices Monitoring
 HSMN NewsFeed - 8 Nov 2012
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Nov 2012
Skagit Valley Hospital Standardizes on Masimo SET(R) Measure-Through Motion and Low Perfusion Pulse Oximetry
Devices Monitoring
 HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2012
Mallinckrodt Completes Acquisition of CNS Therapeutics, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2012
FDA Approves Mallinckrodt’s EXALGO(R) (hydromorphone HCl) Extended-Release Tablets 32 mg (CII) for Opioid-Tolerant Patients with Moderate-to-Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2012
Reckitt Benckiser Pharmaceuticals Inc. Announces FDA Approval of Two New Dosage Strengths of Suboxone(R) Sublingual Film (C-III) for Maintenance Treatment of Opioid Dependence
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Jul 2012
GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2012
Orexo acquires US commercial rights of Abstral and ProStrakan acquires the corresponding rights in the EU and rest of the world
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 May 2012
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2012
Tris Pharma Announces Management Additions, Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2012
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2012
Alkermes Appoints Mark Stejbach as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2012
US Patent Office Rejects All Claims in Second MonoSol Patent
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 26 Jan 2012
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Hydromorphone
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals
 HSMN NewsFeed - 6 Jan 2012
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 5 Jan 2012
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Dec 2011
Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 31 Oct 2011
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL(TM) For Postsurgical Pain Management
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2011
Cubist Pharmaceuticals to Acquire Adolor
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Aug 2011
Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR(R) in Patients with Non-Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Aug 2011
Tris Pharma Expands Leadership Team, Adds Senior Managers in Quality and Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2011
Alternative Pain Therapy for Breast, Prostate and Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jun 2011
Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2011
Caldolor(R) Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2011
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2011
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 May 2011
Acura Pharmaceuticals, Inc. Announces Appointment of Robert Jones as Interim President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, to Take Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2011
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2011
Elite Announces Settlement of Litigation With ThePharmaNetwork
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 27 Jan 2011
REMOXY New Drug Application Accepted by FDA
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 27 Jan 2011
Newly Published Data Demonstrates Caldolor(R) Significantly Reduces Pain and Morphine Use in Post-Operative Patients
Biopharmaceuticals Pain Management Surgery
 HSMN NewsFeed - 25 Jan 2011
Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2011
Furiex Receives FDA Fast Track Designation of MuDelta for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 18 Jan 2011
Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV (acetaminophen) Injection
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jan 2011
Zogenix and Desitin Announce Marketing Approval for SUMAVEL(R) DosePro(TM) in Germany and the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Nov 2010
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 2 Nov 2010
Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV (acetaminophen) injection for the Management of Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Oct 2010
Meda: European Approval for Breakyl
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Oct 2010
Pfizer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Sep 2010
Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jul 2010
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jul 2010
Adolor Corporation Announces Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jun 2010
King Pharmaceuticals Amends Strategic Alliance for REMOXY(R) in Europe
Biopharmaceuticals
 HSMN NewsFeed - 7 Jun 2010
Masimo Initiates Full Market Release of Rainbow Acoustic Monitoring
Devices Monitoring
 HSMN NewsFeed - 24 May 2010
Elite Pharmaceuticals Announces Acquisition of Generic Hydromorphone Product
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 17 May 2010
ROXRO Announces FDA Approval of SPRIX(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 May 2010
Tranzyme Pharma Presents Data Demonstrating that TZP-101 (Ulimorelin) Restores Bowel Function in Patients with Postoperative Ileus (POI) Regardless of the Extent of Opioid Use
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2010
Ethicon Endo-Surgery SEDASYS(R) System Receives Regulatory Approval in Canada and CE Mark in European Union
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 19 Apr 2010
Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2010
QRxPharma Successfully Completes Pivotal Phase 3 Combination Rule Study for MoxDuo(R)IR in Patients with Post-Surgical Pain
Biopharmaceuticals Surgery
 HSMN NewsFeed - 7 Apr 2010
Tris Pharma Announces Key Executive Hiring of Vice President of Corporate Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Apr 2010
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Apr 2010
Tioga Pharmaceuticals Receives Special Protocol Assessment Agreement From FDA for Phase 3 Trials of Asimadoline in Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 26 Mar 2010
Biovail Acquires AMPAKINE(R) Compounds for Treatment of Respiratory Depression
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Feb 2010
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Feb 2010
NeurogesX Announces Management Team Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2010
FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM)
Biopharmaceuticals FDA Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2010
Orexo Announces That Partner Kyowa Hakko Kirin Entered a Joint Distribution Agreement on KW-2246 for Treatment of Cancer Pain in Japan
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jan 2010
DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2010
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2009
Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 14 Dec 2009
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2009
Elite Pharmaceutics and ThePharmaNetwork Announce FDA Approval for Generic Methadone Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Dec 2009
Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring
Devices Monitoring FDA
 HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2009
FDA Extends Review of NDA for Exalgo
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Nov 2009
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2009
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Oct 2009
AcelRx Pharmaceuticals Hires Nigel Ray as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 30 Sep 2009
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Sep 2009
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2009
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2009
Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Aug 2009
Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain
Biopharmaceuticals Drug Delivery Surgery
 HSMN NewsFeed - 5 Aug 2009
Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 4 Aug 2009
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Biopharmaceuticals
 HSMN NewsFeed - 17 Jul 2009
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2009
Meda: Onsolis receives FDA approval
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 15 Jul 2009
Limerick BioPharma Raises $15 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 2 Jul 2009
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jun 2009
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 17 Jun 2009
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2009
NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Jun 2009
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 21 May 2009
NeurogesX Receives European Commission Approval for Qutenza(TM)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 14 May 2009
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2009
DARA BioSciences Announces Positive Trial Results of KRN5500 for Treatment of Neuropathic Pain in Patients With Cancer
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 7 May 2009
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 6 May 2009
Ergomed Signs Co-Development Collaboration Agreement With Genzyme Corporation to Develop Tasidotin in Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2009
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 23 Mar 2009
Covidien Receives FDA Clearance for the Nellcor OxiMax N-600x Pulse Oximeter with OxiMax SPD Alert
Devices Monitoring FDA
 HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
Biopharmaceuticals Pain Management Regulatory
 HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2009
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2009
ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Jan 2009
Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2009
Targin(R) (Oral Oxycodone/Naloxone Prolonged-Release Tablet) now Launching Across Europe to Control Severe Chronic Pain With Significantly Reduced Risk of Opioid-Induced Constipation
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2009
Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jan 2009
Meda Acquires World-Wide Rights to Onsolis
Biopharmaceuticals Distribution
Return to NewsFeed  

 Additional items found! 242

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 242 additional stories matching:
opioid
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!